KRAS mutations in squamous cell carcinomas of the lung

  • KRAS is one of the most commonly mutated oncogenes in cancer, enabling tumor proliferation and maintenance. After various approaches to target KRAS have failed over the past decades, the first specific inhibitor of the p.G12C mutation of KRAS was recently approved by the FDA after showing promising results in adenocarcinomas of the lung and other solid tumors. Lung cancer, the most common cancer worldwide, is a promising use case for these new therapies, as adenocarcinomas in particular frequently harbor KRAS mutations. However, in squamous cell carcinoma (SCC) of the lung, KRAS mutations are rare and their impact on clinical outcome is poorly understood. In this review, we discuss the current knowledge on the prevalence and prognostic and predictive significance of KRAS mutations in the context of SCC.

Download full text files

Export metadata

Metadaten
Author:Fabian AckerORCiDGND, Jan Alexander StratmannORCiDGND, Lukas Julian AspacherGND, Ngoc Thien Thu NguyenORCiDGND, Sebastian Alexander WagnerORCiDGND, Hubert ServeORCiDGND, Peter Johannes WildORCiDGND, Martin SebastianORCiDGND
URN:urn:nbn:de:hebis:30:3-620714
DOI:https://doi.org/10.3389/fonc.2021.788084
ISSN:2234-943X
Parent Title (English):Frontiers in oncology
Publisher:Frontiers Media
Place of publication:Lausanne
Document Type:Article
Language:English
Date of Publication (online):2021/12/15
Date of first Publication:2021/12/15
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2024/10/01
Tag:KRAS; NSCLC; RAS; lung squamous cell carcinoma (LUSC); review
Volume:11
Issue:art. 788084
Article Number:788084
Page Number:7
First Page:1
Last Page:7
Note:
Gefördert durch den Open-Access-Publikationsfonds der Goethe-Universität
Institutes:Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Open-Access-Publikationsfonds:Medizin
Licence (German):License LogoCreative Commons - CC BY - Namensnennung 4.0 International